ARS Pharmaceuticals, Inc. SPRY Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
- ARS Pharmaceuticals, Inc. (SPRY) reported increase (decrease) in prepaid expense and other assets of $524K in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- ARS Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 89.1% year-over-year, from $4.8M to $524K.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a -13.5% compound annual growth rate (CAGR), from -$1.17M to -$656K.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.